The Print on MSN9h
Top pharma alliance refutes ‘ill-researched’ US study linking Indian generics to higher adverse events
Indian Pharmaceutical Alliance says the study relies on FDA Adverse Event Reporting System data, which captures link between ...
IPA refutes US univ's report questioning quality of Indian-made generics
Asserting that quality standards are not region-dependent, the Indian Pharmaceutical Alliance (IPA) on Wednesday refuted the ...
Devdiscourse3d
USFDA Warns Granules India Over Facility Violations
The USFDA has criticized Granules India for inadequate maintenance and cleaning procedures at its Telangana plant, leading to ...
Granules India gets US food regulator's warning for lapses at Telangana plant
The USFDA inspected the facility from August 26 to September 6, 2024 and observed issues in the cleaning and maintenance of ...
Indian pharma sector sees growth at 8% CAGR, export rates spike by 9% in 2024: Report
The Indian pharma sector has grown at 8 per cent CAGR and has also seen a 9 per cent increase in export rates in 2024, ...
Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
The Daily Reporter7d
Trump administration terminates 16 federal office leases in Wisconsin
An initiative by the Trump administration said it has canceled 16 federal office leases in Wisconsin, cutting 18.4 of leased ...
The Financial Express13d
Indian pharma rises to global prominence led by export boom and better compliance rates, McKinsey report reveals
India has emerged as the world’s largest supplier of generic medicines, with a 9% pharma export growth rate, nearly double ...